Semimechanistic Physiologically‐Based Pharmacokinetic/Pharmacodynamic Model Informing Epcoritamab Dose Selection for Patients With B‐Cell Lymphomas

por Li, Tommy, Hiemstra, Ida H., Chiu, Christopher, Oliveri, Roberto S., Elliott, Brian, DeMarco, Dena, Salcedo, Theodora, Egerod, Frederikke Lihme, Sasser, Kate, Ahmadi, Tahamtan, Gupta, Manish
Publicado 2022

Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program

por Du, Xin, Jin, Jie, Cai, Zhen, Chen, Fangping, Zhou, Dao-bin, Yu, Li, Ke, Xiaoyan, Li, Xiao, Wu, Depei, Meng, Fanyi, DeMarco, Dena, Zhang, Jingshan, Mei, Jay, Hou, Jian
Publicado 2016